Enlivex Therapeutics
ENLV
ENLV
9 hedge funds and large institutions have $8.92M invested in Enlivex Therapeutics in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VAM
1
Visium Asset Management
New York
| $5.82M | 844,000 | -160 | -0% |
|
|
KCM
2
Knoll Capital Management
Miami,
Florida
| $2.33M | 338,110 | – | – |
|
|
OC
3
Oppenheimer & Co
New York
| $490K | 71,147 | +20,987 | +42% |
|
4
HighTower Advisors
Chicago,
Illinois
| $248K | 36,000 | +36,000 | New |
|
5
UBS Group
Zurich,
Switzerland
| $24K | 3,470 | +3,470 | New |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $7K | 1,000 | – | – |
|
7
Citigroup
New York
| $4K | 603 | +603 | New |
|
8
Wells Fargo
San Francisco,
California
| $2K | 300 | -500 | -63% |
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | 200 | +200 | New |
|
|
SIM
10
Spark Investment Management
New York
| – | – | -17,400 | Closed |
|
11
Morgan Stanley
New York
| – | – | -724 | Closed |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | – | -575 | Closed |
|